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Background: Four single nucleotide polymorphisms (SNPs) (rs2237892, rs2237895, rs2237897, and rs2283228) in
KCNQ1 are reported to be associated with type 2 diabetes mellitus (T2DM), possibly caused by a reduction in
insulin secretion and higher fasting glucose, but the results are inconsistent. We investigated whether these 4
genetic markers are associated with serum lipid metabolism in a middle-aged Chinese Han population.
Methods: We enrolled 398 consecutive patients, including 180 with premature coronary artery disease (CAD) (male
< 55 years, female < 65 years) and 218 controls without documented CAD. All subjects were genotyped for 4 SNPs
by using the ligase detection reaction method. Fasting blood sugar (FBS) and plasma concentrations of total
cholesterol, triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-
C), apolipoprotein A1(apo A1), and apolipoprotein B (apo B) were determined by standard biochemical methods.
Main anthropometric and metabolic characteristics are analyzed among 3 genotypes at rs2283228, rs2237895,
rs2237897, or rs2237892 in KCNQ1.
Results: The 3 genotypes AA, AC, and CC were present in rs2283228 and rs2237895, and the 3 genotypes CC, CT,
and TT were present in rs2237897 and rs2237892. The minor genotypes CC at rs2283228 and TT at rs2237892 were
associated with higher levels of TG (P = 0.007 and 0.026, respectively). Furthermore, subjects with the CC genotype
at rs2283228 had lower levels of HDL-C and apo A1 than in the other 2 genotype groups (P = 0.052 and 0.055,
respectively). No other associations were detected between these 4 SNPs and FBS or other lipid parameters.
Conclusions: Our data suggest that rs2283228 and rs2237892 in KCNQ1 are associated with lipid metabolism in a
middle-aged Chinese Han population.
Background
KCNQ1, which is located at chromosome 11p15.5 and
near a candidate region at 11p13-p12 and mainly
encodes a protein for a voltage-gated potassium channel
required for the repolarization phase of the cardiac
action potential, has been proved to be associated with
type 2 diabetes mellitus (T2DM). Studies done by differ-
ent groups show that some common single nucleotide
polymorphisms (SNPs) in KCNQ1, acting as T2DM sus-
ceptibility genes, exist in different ancestral groups
including in the Asian populations of the Japanese, Kor-
ean, and Chinese in Hong Kong and Shanghai [1-5].
Among these are the 4 common SNPs rs2237892,
rs2237895, rs2237897, and rs2283228 that were well
replicated. However, controversies still exist in which
these SNPs in KCNQ1 are not implicated as T2DM sus-
ceptibility genes in individuals of European descent [6,7]
or in a middle-aged population from East China [8].
Owing to the lack of consistent replication of these
results in case-control studies in different study popula-
tions, it remains to be determined whether the results
derived from Western societies are internationally
applicable to East Asian races or specifically the Chinese
Han population, or whether genetic background can
cause different clinical phenotypes of the same disease
as coronary artery disease (CAD) or T2DM.
Only recently have scholars demonstrated that the
increased risk for T2DM linked to SNPs in KCNQ1 is
likely to be caused by a reduction in insulin secretion,
higher levels of fasting glucose or HbA1c [5,9,10], which
implies that the KCNQ1 variants may play a major
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ance of blood glucose. Furthermore, some other gene
polymorphisms such as hepatocyte nuclear factor-1
homeobox A (HNF1A) gene polymorphisms [11], PPAR-
gamma gene C161T polymorphism [12] and adiponectin
receptor-2 gene variations [13] have also been proved to
be connected with diabetes and cardiovascular disease.
Given that it is still unknown whether these 4 SNPs in
KCNQ1 are associated with plasma lipid parameters
besides their inconsistent association with T2DM [1-10],
to fill this knowledge gap, we aimed to determine
whether these 4 common SNPs at KCNQ1 loci would
correlate with plasma lipid parameters in a middle-aged
Chinese Han population living in East China. The
results will help solve this apparent controversy and
provide new evidence to elucidate the mechanism of
KCNQ1 variants on the risk of T2DM and CAD.
Methods
Study population samples
The study population has been previously described [8].
Briefly, from January 2003 to August 2008, 398 patients
undergoing coronary angiography (CAG) for chest dis-
comfort or suspected CAD were enrolled in this study,
including 180 patients (men age 32-54 years and women
age 39-64 years) with documented premature CAD [14]
and 218 subjects without coronary stenosis, acting as
controls. CAD was defined as a significant coronary ste-
nosis (≥ 50%) in at least one of the 3 main coronary
arteries or their major branches (branch diameter ≥ 2
mm) assessed by CAG or having experienced a myocar-
dial infarction (MI) defined according to World Health
Organization criteria. All patients with type 1 diabetes
mellitus, congenital heart disease, syndrome X, severe
liver or kidney disease, or noncoronary artery thrombo-
tic disease were excluded from this study. The study
was approved by the Medical Ethics Committee of the
Affiliated ZhongDa Hospital of Southeast University.
Before enrollment, the trial information was explained
carefully to each patient, and subsequently written
informed consent was obtained from all participants.
Coronary angiography
All participants underwent CAG during hospitalization.
The grade of the coronary stenosis and CAD diagnosis
were judged by 2 cardiologists unaware of this study.
Determination of parameters and risk factors
At the time of enrollment, background data, such as sex,
age, height, body weight, and risk factors including
hypertension, T2DM, family history of CAD, and smok-
ing status were collected from each subject. Anthropo-
metric measurements and blood pressure determination
were performed according to standard protocols. Blood
was collected and plasma concentrations of total choles-
terol (TC), triglycerides (TG), high-density lipoprotein
cholesterol (HDL-C), and low-density lipoprotein cho-
lesterol (LDL-C) were analyzed as previously described
[15]. Levels of apolipoprotein A1 (apo A1), apolipopro-
tein B (apo B), fasting blood sugar (FBS), and insulin
were determined by standard biochemical methods
using a chemistry analyzer (Beckman Coulter Synchron
clinical system LX20). Insulin resistance was calculated
from fasting insulin and glucose by using the homeosta-
sis model assessment method [16].
Determination of hypertension, T2DM, family history
of CAD, and smoking status has been previously
described [8]. Body weight and height were measured
with individuals wearing light clothing, and body mass
index (BMI) is expressed as weight in kilograms divided
by the square of the height in meters.
DNA extraction and genotyping
Genomic DNA extraction and genotyping of 4 SNPs in
intron 15 of KCNQ1 have been described previously [8].
Genotype distributions obeyed the Hardy-Weinberg
equilibrium (P > 0.05).
Statistical analyses
Statistical analyses were conducted using SPSS 15.0 soft-
ware. Continuous data are expressed as mean ± SD, and
categorical variables are expressed as frequencies. Ana-
lyses of continuous data and categorical variables among
3 different groups according to the genotypes of these 4
SNPs at KCNQ1 were determined by one-way ANOVA
or chi-square test. Two-tailed P-values <0.05 were con-
sidered as significant.
Results
Analysis of baseline characteristics in patients among 3
different genotypic groups (Table 1 and Table 2)
The 3 genotypes AA, AC, and CC are in rs2283228 and
rs2237895, and the 3 genotypes CC, CT, and TT are in
rs2237897 and rs2237892. When all study subjects were
divided into 3 groups as the AA, AC, and CC group in
rs2283228 and rs2237895, or the CC, CT, and TT group
in rs2237897 and rs2237892, we found that 3 groups were
well matched for mean age and gender composition. Sub-
jects with the CC genotype in rs2283228 and TT genotype
in rs2237892 had significantly higher levels of TG com-
pared with the other 2 groups (P < 0.05), but this was not
the case in subjects with the CC genotype in rs2237895 or
TT genotype in rs2237897 (data not shown).
Overall in the study population, no significant differ-
ences were detected in the prevalences of hypertension,
T2DM, family history of CAD, smoking, and average
values of BMI, FBS, insulin, TC, LDL-C, and homeosta-
sis model assessment of insulin resistance (HOMA-IR)
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SNPs in KCNQ1 (all P > 0.05).
Despite the lack of association between genotypes and
TC, LDL-C, and apo B, concentrations of HDL-C and
apo A1 in the CC group in rs2283228 were lower at the
borderline significance level compared with the other 2
groups (P = 0.052 and 0.055, respectively). No other
associations were detected between concentrations of
HDL-C, apo A1, and apo B and SNPs at rs2237892,
rs2237895, or rs2237897 (all P > 0.05).
Table 1 Comparisons of anthropometric and metabolic characteristics among 3 genotypes at rs2283228
Genotype P
rs2283228 AA AC CC
Numbers 156 191 51
Sex, male (n/%) 77/49.3 90/47.1 27/52.9 0.746
Age, years 51.67 ± 5.50 51.28 ± 5.47 52.53 ± 5.72 0.836
Hypertension, n/% 83/53.2 121/63.3 31/60.7 0.155
Type 2 diabetes mellitus, n/% 21/13.5 29/15.2 7/13.7 0.894
Family history of CAD, n/% 64/41.0 73/38.2 17/33.3 0.609
Smokers, n/% 53/33.9 69/36.1 17/33.3 0.887
BMI, kg/m
2 24.29 ± 3.46 24.93 ± 3.81 24.33 ± 3.00 0.227
FBS, mmol/L 5.73 ± 1.72 5.57 ± 0.98 5.87 ± 1.86 0.408
Insulin, mU/L 14.31 ± 11.87 13.16 ± 9.84 17.32 ± 13.08 0.351
HOMA-IR 3.64 ± 0.59 3.56 ± 0.57 4.36 ± 0.83 0.138
TC, mmol/L 4.65 ± 0.93 4.39 ± 0.86 4.63 ± 0.78 0.116
TG, mmol/L 1.53 ± 0.76 1.50 ± 0.80 2.03 ± 0.84 0.007
LDL-C, mmol/L 2.82 ± 0.80 2.71 ± 0.74 2.74 ± 0.84 0.604
HDL-C, mmol/L 1.21 ± 0.30 1.14 ± 0.25 1.07 ± 0.22 0.052
Apo A1, g/L 1.15 ± 0.18 1.11 ± 0.19 1.08 ± 0.16 0.055
Apo B, g/L 0.87 ± 0.25 0.86 ± 0.25 0.97 ± 0.23 0.115
Data are mean ± SD, or number (%), as appropriate.
P is the significance level of comparison of clinical and plasma parameters among 3 groups by one-way ANOVA or chi-square test.
Apo A1, apolipoprotein A1; Apo B, apolipoprotein B; BMI, body mass index; CAD, coronary artery disease; FBS, fasting blood sugar; HDL-C, high-density
lipoprotein cholesterol; HOMA-IR, homeostasis model assessment-insulin resistance; LDL-C, low-density lipoprotein cholesterol; SNPs, single nucleotide
polymorphisms; TC, total cholesterol; TG, triglyceride.
Table 2 Comparisons of anthropometric and metabolic characteristics among 3 genotypes at rs2237892
Genotype P
rs2237892 CC CT TT
Numbers 189 168 41
Sex, male (n/%) 92/48.7 81/48.2 21/51.2 0.942
Age, years 51.04 ± 5.48 51.96 ± 5.50 52.64 ± 5.39 0.864
Hypertension, n/% 106/56.1 101/60.1 28/68.3 0.330
Type 2 diabetes mellitus, n/% 27/14.3 24/14.3 6/14.6 0.998
Family history of CAD, n/% 73/38.6 63/37.5 18/43.9 0.752
Smokers, n/% 63/33.3 61/36.3 15/36.6 0.818
BMI, kg/m
2 24.34 ± 3.35 24.89 ± 3.94 24.59 ± 3.00 0.362
FBS, mmol/L 5.73 ± 1.61 5.51 ± 0.94 6.04 ± 2.01 0.120
Insulin, mU/L 13.70 ± 11.28 13.43 ± 10.02 18.66 ± 13.04 0.232
HOMA-IR 3.68 ± 0.69 3.51 ± 0.59 4.78 ± 0.81 0.437
TC, mmol/L 4.60 ± 0.90 4.41 ± 0.90 4.75 ± 0.66 0.157
TG, mmol/L 1.60 ± 0.83 1.48 ± 0.74 2.01 ± 0.87 0.026
LDL-C, mmol/L 2.77 ± 0.78 2.72 ± 0.77 2.85 ± 0.82 0.759
HDL-C, mmol/L 1.19 ± 0.29 1.14 ± 0.25 1.09 ± 0.25 0.178
Apo A1, g/L 1.14 ± 0.18 1.08 ± 0.19 1.12 ± 0.18 0.095
Apo B, g/L 0.88 ± 0.26 0.85 ± 0.25 0.92 ± 0.21 0.072
Abbreviations see Table 1.
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In the present study, for the first time, we report a
strong association between rs2283228 and rs2237892 in
KCNQ1 and lipid metabolism in a middle-aged Chinese
Han population, which adds new data to this study
issue.
Better understanding and preventive strategies for the
morbidity and mortality related to T2DM are compel-
ling. Recently, some susceptibility genes for T2DM have
been reported [1-4], and potential mechanisms have also
been elucidated [5,9,10]. However, inconsistent results
still exist [6-8], and other mechanisms could not be
fully excluded.
In the study by Tan JT et al [9], a total of 3 734 parti-
cipants (2 520 Chinese, 693 Malay, and 521 Asian
Indians) living in Singapore were enrolled, among which
1 881 Chinese subjects with normal glucose tolerance
served as controls, and the reference population had an
age range from 18 to 69 years. In the study by Liu Y
et al [5], there were more women in both T2DM cases
(women, 1 127; men, 785) and controls (women, 1 406;
men, 635) and higher average age [(63.9 ± 9.5) years vs.
(58.1 ± 9.4) years] than in our study. For the present
study, all participants were aged 32 to 64 years and
were hospitalized for CAD screening, among which
14.3% of subjects were diagnosed with T2DM, 180 sub-
jects (45.2%) had CAD, and 218 subjects (54.8%) were
n o n - C A Dc o n t r o l s[ 8 ] .Y o u n gC A Dp a t i e n t su s u a l l y
have a different profile of major coronary risk factors
[17]. Obviously, the differences in enrollment criteria
and population characteristics account for the discre-
pancies between these studies. Meanwhile, differences in
genetic inheritance among the races, lifestyles, public
health insurance, and a system of free access to hospitals
might contribute to the available subjects enrolled in
our study.
In the current study, subjects in 3 groups according to
different genotypes at rs2283228, rs2237895, rs2237897,
and rs2237892 were well matched for mean age and
gender composition, and no significant differences were
detected in the prevalences of hypertension, T2DM,
family history of CAD, smoking and values of BMI, FBS,
insulin, TC, LDL-C, and HOMA-IR.
More recently, emerging evidence supports TG as a
risk factor for CAD [18,19]. Patients with T2DM are
more likely to have higher levels of TG and lower levels
of HDL-C. Our study thus furthermore helps settle the
issue of whether the variants in KCNQ1 are related to
lipid metabolism. In the present study, we demonstrated
that an association exists between CC genotype in
rs2283228 and TT genotype in rs2237892 and higher
levels of TG. Further fine mapping of SNPs in KCNQ1,
especially within the LD block containing rs2283228 or
rs2237892, may allow the eventual identification of the
causal variant. Meanwhile, in the study by Giuffrida et
al, though HNF1A I27L polymorphism did not differ
significantly among late-onset autosomal dominant dia-
betes mellitus, classical T2DM and normoglycemic con-
trols, it was found to be associated with risk of
hypertriglyceridemia [11]. In patients with CAD com-
bined with T2DM, P PARgamma C161 > T genotypes
are associated with levels of TG and apo B but not glu-
cose metabolism, with CC homozygote carriers having
significantly higher levels of TG and apo B than those in
T allele carriers [12]. Large prospective studies have
identified HDL-C as a strong, independent, inverse pre-
dictor of risk of CAD [20,21]. Patients with higher levels
of HDL-C and CAD had a similar or lower prevalence
of traditional CAD risk factors compared with patients
with normal HDL-C levels and CAD [22]. In our study,
subjects with CC genotype in rs2283228 had lower
levels of HDL-C and apo A1.
Some limitations of the present study need to be
acknowledged. First, our study population comprised
only those who have been admitted to the hospital for
CAD screening and diagnosis, so it’sm o r er e p r e s e n t a -
tive of patients in a cardiac center and might not be
representative of the general population. Additionally,
our study sample is predominantly yellow; thus, the
results may not be generalizable to other ethnic groups
in which disparities in population composition, geogra-
phical, and ethnic backgrounds may exist. It is well
known that significant differences exist in the frequen-
cies of some genetic variations among different ethnic
groups and geographical regions. The fact is that these
novel observations have not been previously found in
other ethnic groups.
Conclusion
Our novel findings that the risk alleles of rs2283228 and
rs2237892 within the KCNQ1 gene are associated with
levels of TG, HDL-C and apo A1 in a middle-aged Chi-
nese Han population are encouraging. Though the cau-
sal effects of four common SNPs (rs2237892, rs2237895,
rs2237897, and rs2283228) in KCNQ1 on T2DM are
controversial, our present study, for the first time, pro-
vide new evidence that these variants have an effect on
lipid metabolism. Further studies are needed to firmly
replicate these promising findings in other populations
and to fully delineate the role of KCNQ1 and its related
pathways in the pathogenesis of T2DM and CAD.
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